Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer

Beyond PD-L1—Identification of Further Potential Therapeutic Targets in Oral Cancer

Background: The involvement of immune cell infiltration and immune regulation in the progression of oral squamous cell carcinoma (OSCC) is shown. Anti-PD-1 therapy is approved for the treatment of advanced OSCC cases, but not all patients respond to immune checkpoint inhibitors. Hence, further targe...

Full description

Bibliographic Details
Main Authors: Manuel Weber, Rainer Lutz, Manuel Olmos, Jacek Glajzer, Christoph Baran, Christopher-Philipp Nobis, Tobias Möst, Markus Eckstein, Marco Kesting, Jutta Ries
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
immune checkpoints
OSCC
immunotherapy
head and neck cancer
HNSCC
macrophage
Online Access:https://www.mdpi.com/2072-6694/14/7/1812

Internet

https://www.mdpi.com/2072-6694/14/7/1812

Similar Items